Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives
Open Access
- 4 April 2020
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 27 (6), 491-503
- https://doi.org/10.1111/iju.14229
Abstract
Interstitial cystitis/bladder pain syndrome is a debilitating condition of unknown etiology characterized by persistent pelvic pain with lower urinary tract symptoms and comprises a wide variety of potentially clinically useful phenotypes with different possible etiologies. Current clinicopathological and genomic evidence suggests that interstitial cystitis/bladder pain syndrome should be categorized by the presence or absence of Hunner lesions, rather than by clinical phenotyping based on symptomatology. The Hunner lesion subtype is a distinct inflammatory disease with proven bladder etiology characterized by epithelial denudation and enhanced immune responses frequently accompanied by clonal expansion of infiltrating B cells, with potential engagement of infection. Meanwhile, the non‐Hunner lesion subtype is a non‐inflammatory disorder with little evidence of bladder etiology. It is potentially associated with urothelial malfunction and neurophysiological dysfunction, and frequently presents with somatic and/or psychological symptoms, that commonly result in central nervous sensitization. Animal models of autoimmune cystitis and neurogenic sensitization might serve as disease models for the Hunner lesion and non‐Hunner lesion subtypes, respectively. Here, we revisit the taxonomy of interstitial cystitis/bladder pain syndrome according to current research, and discuss its potential pathophysiology and representative animal models. Categorization of interstitial cystitis/bladder pain syndrome based on cystoscopy is mandatory to design optimized treatment and research strategies for each subtype. A tailored approach that specifically targets the characteristic inflammation and epithelial denudation for the Hunner lesion subtype, or the urothelial malfunction, sensitized/altered nervous system and psychosocial problems for the non‐Hunner lesion subtype, is essential for better clinical management and research progress in this complex condition.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (18060798)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01‐DK‐111396)
This publication has 153 references indexed in Scilit:
- Increased Urothelial Cell Apoptosis and Chronic Inflammation Are Associated with Recurrent Urinary Tract Infection in WomenPLOS ONE, 2013
- Alterations of microbiota in urine from women with interstitial cystitisBMC Microbiology, 2012
- BALB/c-Fcgr2b−/−Pdcd1−/− mouse expressing anti-urothelial antibody is a novel model of autoimmune cystitisScientific Reports, 2012
- Autoimmunity to Uroplakin II Causes Cystitis in Mice: A Novel Model of Interstitial CystitisEuropean Urology, 2012
- Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cellsMucosal Immunology, 2011
- Models of inflammation of the lower urinary tractNeurourology and Urodynamics, 2011
- Diet restriction in migraine, based on IgG against foods: A clinical double-blind, randomised, cross-over trialCephalalgia, 2010
- Cross‐talk and sensitization of bladder afferent nervesNeurourology and Urodynamics, 2009
- RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis modelJournal of Autoimmunity, 2008
- Toll-like receptors in systemic autoimmune diseaseNature Reviews Immunology, 2006